Liberal fluid intake found safe and linked to lower symptom burden in stable chronic HF

Long-term clopidogrel monotherapy superior to aspirin in high ischemic risk patients post-PCI: Results from the SMART-CHOICE 3 trial

Extended reduced-dose apixaban as an effective and safer alternative to full-dose therapy in cancer-associated VTE: Results from the API-CAT study

Semaglutide improves walking capacity and QoL in patients with symptomatic PAD and T2D: Results from the phase 3b STRIDE trial

Evolut TAVR demonstrates long-term durability and safety comparable to surgical valve replacement in low-risk aortic stenosis patients